SZ 161 (Ropinirole hydrochloride extended-release 8mg)
Pill imprint SZ 161 has been identified as Ropinirole hydrochloride extended-release 8mg.
Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- SZ 161
- Strength:
- 8mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Inc.
- National Drug Code (NDC):
- 00781-5786
- Inactive Ingredients:
- carboxymethylcellulose sodium
silicon dioxide
hydrogenated castor oil
hydroxypropyl cellulose
hypromelloses
ferric oxide red
lactose anhydrous
magnesium stearate
magnesium silicate
polyethylene glycol
ferrosoferric oxide
titanium dioxide
diethyl phthalate
maltodextrin
ferric oxide yellow
ethylcelluloses
More about ropinirole
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
